ロード中...
Appropriateness of Dabigatran and Rivaroxaban Prescribing for Hospital Inpatients
BACKGROUND: Recent approval of the new oral anticoagulants dabigatran and rivaroxaban has led to rapid changes in anticoagulant prescribing practices. Postmarketing reports have highlighted safety concerns with these agents, and their use outside of evidence-based recommendations was noted at the au...
保存先:
| 出版年: | Can J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Canadian Society of Hospital Pharmacists
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4924939/ https://ncbi.nlm.nih.gov/pubmed/27402998 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|